Prevention and Treatment of Arterial Thrombosis in Pregnancy

Peter Clark; Ian A. Greer

doi:10.1055/s-2003-38830

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2003; 29(2): 155-164
DOI: 10.1055/s-2003-38830

Prevention and Treatment of Arterial Thrombosis in Pregnancy

Peter Clark¹ , Ian A. Greer²

¹Consultant Hematologist, Department of Transfusion Medicine, Ninewells Hospital and Medical School, Dundee, UK
²University Department Obstetrics & Gynaecology, Royal Infirmary, Glasgow, UK

Abstract

ABSTRACT

In the last few years there has been a marked increase in the recognition of patients who are potentially at risk of arterial occlusive events during pregnancy. This includes patients with a previous history of arterial occlusion such as myocardial infarction and stroke, patients known to carry acquired or inherited thrombotic risk factors including sickle cell and myeloproliferative disorders, and patients with prosthetic heart valves. This review details the management options for prevention of arterial occlusions in these at-risk patients and outlines potential management strategies for arterial occlusions occurring during pregnancy.

KEYWORDS

Arterial thrombosis - pregnancy - thrombotic risk factors - prosthetic heart valves - sickle cell disease - management

Full Text

References

REFERENCES

1 Poort S, Rosendaal F, Reitsma P, Bertina K. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of venous thrombosis. Blood . 1996; 88 3698-3703
2 Kang S, Wong P, Susmano A. et al . Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Hum Genet . 1991; 48 536-539
3 Nelen W, Steegers E, Eskes T, Blom H. Genetic risk factors for unexplained early pregnancy loss. Lancet . 1997; 350 861
4 Rosendaal F, Siscovick D, Schwartz S. et al . A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood . 1997; 90 1747-1750
5 Folsom A, Rosamond W, Shahar E. et al . Prospective study of markers of haemostatic function with risk of ischemic stroke. Circulation . 1999; 100 736-742
6 Rosendaal F. High levels of factor VIII and venous thrombosis. Thromb Haemost . 2000; 83 1-2
7 Wouters M, Boers G, Blom H. et al . Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril . 1993; 60 820-825
8 Chan W, Anand S, Ginsberg J. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med . 2000; 160 191-196
9 Gohlke-Barwolf C, Acar J, Burckhardt D. et al . Guidelines for the prevention of thromboembolic events in valvular heart disease. J Heart Valve Dis . 1993; 2 398-410
10 Bortolloti U, Milano A, Mazzucco A. Pregnancy in patients with a porcine valve prosthesis. Am J Cardiol . 1982; 50 1051-1054
11 Nunez L, Larrea J, Gil Aguado M. et al . Pregnancy in 20 patients with bioprosthetic valve replacement. Chest . 1983; 84 26-28
12 Badduke B, Jamieson W, Miyagashima R. et al . Pregnancy and childbearing in a population with biologic heart protheses. J Thorac Cardiovasc Surg . 1991; 102 179-186
13 Jamieson W, Miller D, Akins C. et al . Pregnancy and bioprostheses: influence on structural valve deterioration. Ann Thorac Surg . 1995; 60 S282-S287
14 Sbarouni E, Oakley C. Outcome of pregnancy in women with valve prothesis. Br Heart J . 1994; 71 196-201
15 North R, Sadler L, Stewart A. et al . Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation . 1999; 99 2669-2676
16 L'E Orme M, Lewis P, de Swiet M. et al . May mothers given warfarin breast feed their infants. Br Med J . 1977; 1 1564-1565
17 McKenna R, Cole E, Vasan U. Is warfarin sodium contraindicated in the lactating mother?. J Pediat . 1983; 103 325-327
18 Ginsberg J. Fetal abnormalities and anticoagulants. In: Greer IA, Turpie AGG, Forbes CD, eds. Haemostasis and Thrombosis in Obstetrics and Gynaecology London: Chapman & Hall 1992: 361-369
19 Hall J, Pauli R, Wilson K. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med . 1980; 68 122-140
20 Shaul W, Hall J. Multiple congenital anomalies associated with oral anticoagulants. Am J Obstet Gynecol . 1977; 127 191-198
21 Ginsberg J, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest . 2001; 119 122S-131S
22 Greer I. Haemostasis and thrombosis in pregnancy. In: Forbes C, Thomas D, Tuddenham E, eds. Haemostasis and Thrombosis Edinburgh: Churchill Livingstone 1994: 987-1015
23 Flessa H, Kapstrom A, Glueck H, Will J. Placental transport of heparin. Am J Obstet Gynecol . 1963; 28 469-472
24 Ginsberg J, Hirsh J, Turner C. et al . Risks to the fetus of anticoagulation therapy during pregnancy. Thromb Haemost . 1989; 61 197-203
25 Ginsberg J, Kowalchuk G, Hirsh J. et al . Heparin therapy during pregnancy: risks to the fetus and mother. Arch Intern Med . 1989; 149 2233-2236
26 Ginsberg J, Kowalchuk G, Hirsh J. et al . Heparin effect on bone density. Thromb Haemost . 1990; 64 286-289
27 Kelton J, Levine M. Heparin-induced thrombocytopaenia. Semin Thromb Hemost . 1986; 12 59-62
28 Warkentin T, Levine M, Hish J. et al . Heparin-induced thrombocytopaenia in patients treated with low molecular weight or unfractionated heparin. N Engl J Med . 1995; 332 1330-1335
29 Dahlman T, Sjoberg H, Ringertz H. Bone mineral density during long-term prophylaxis with heparin in pregnancy. Am J Obstet Gynecol . 1994; 170 1315-1320
30 Barbour L, Kick S, Steiner J. et al . A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol . 1994; 170 862-869
31 Dahlman T. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol . 1993; 168 1265-1270
32 Monreal M, Lafoz E, Olive A, del Rio L, Bedia C. Comparison of subcutaneous unfractionated heparin (Fragmin) in patients with venous thromboembolism and contraindication to coumarin. Thromb Haemost . 1994; 71 7-11
33 Shaughnessy S, Hirsh J, Bhandari M. et al . Histomorphometric evaluation of heparin-induced bone loss after discontinuation of heparin treatment in rats. Blood . 1999; 93 1231-1236
34 Muir J, Andrew M, Hirsh J. et al . Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo. Blood . 1996; 88 1314-1320
35 Melissari E, Parker C, Wilson N. et al . Use of low molecular weight heparin in pregnancy. Thromb Haemost . 1992; 68 652-656
36 Shefras J, Farquharson R. Bone density studies in pregnant women receiving heparin. Eur J Obstet Gynecol Reprod Biol . 1996; 65 171-174
37 Muir J, Hirsh J, Wietz J. et al . A histomorphometric comparison of the effects of heparin and low molecular weight heparin on cancellous bone in rats. Blood . 1997; 89 3236-3242
38 The Collaborative Low Dose Aspirin Study Group. CLASP: A randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet . 1994; 343 619-629
39 Salazar E, Zajarias A, Gutierrez N, Iturbe I. The problem of cardiac valve prostheses, anticoagulants, and pregnancy. Circulation . 1984; 70 169-177
40 Ibarra-Perez C, Arevalo-Toledo N, Alvarez-de la Cadena O, Noriega-Guerra L. The course of pregnancy in patients with artificial heart valves. Am J Med . 1976; 61 504-512
41 Lutz D, Noller K, Spittell J, Danielson G, Fish C. Pregnancy and its complications following cardiac valve prostheses. Am J Obstet Gynecol . 1978; 131 460-468
42 Chen W, Chan C, Lee P, Wang R, Wong V. Pregnancy in patients with prosthetic heart valves: an experience with 45 pregnancies. Q J Med . 1982; 51 358-365
43 O'Neill H, Blake S, Sugrue D, Macdonald D. Problems in the management of patients with artificial valves during pregnancy. Br J Obstet Gynaecol . 1982; 89 940-943
44 Sheikhzadeh A, Ghabusi P, Hakim S. et al . Congestive heart failure in valvular heart disease in pregnancies with and without valvular prostheses and anticoagulant therapy. Clin Cardiol . 1983; 6 465-470
45 Vitali E, Donatelli F, Quaini E, Groppelli G, Pellegrini A. Pregnancy in patients with mechanical prosthetic heart valves. Our experience regarding 98 pregnancies in 57 patients. J Cardiovasc Surg . 1986; 27 221-227
46 Ben Ismail M, Abid F, Trabelsi S, Taktak M, Fekih M. Cardiac valve prostheses, anticoagulation, and pregnancy. Br Heart J . 1986; 55 101-105
47 Lee P, Wang R, Chow J. et al . Combined use of warfarin and adjusted subcutaneous heparin during pregnancy in patients with an artificial heart valve. J Am Coll Cardiol . 1986; 8 221-224
48 Born D, Martinez E, Almeida P. et al . Pregnancy in patients with prosthetic heart valves: the effects of anticoagulation on mother, fetus, and neonate. Am Heart J . 1992; 124 413-417
49 Gallus A S. Anticoagulants in the prevention and treatment of thromboembolic problems in pregnancy, including cardiac problems. In: Greer IA, Turpie AGG, Forbes CD, eds. Haemostasis and Thrombosis in Obstetrics and Gynaecology London: Chapman & Hall 1992: 319-347
50 Caruso A, de Carolis S, Ferrazzani S. et al . Pregnancy outcome in women with cardiac valve prosthesis. Eur J Obstet Gynecol Reprod Biol . 1994; 54 7-11
51 Clark P, Brennand J, Conkie J A. et al . Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost . 1998; 79 1166-1170
52 Gibson J, Ekevall K, Walker I D, Greer I. Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin. Br J Obstet Gynaecol . 1998; 105 795-796
53 Nelson-Piercy C, Letsky E, de Swiet M. Low molecular weight heparin for obstetric thromboprophylaxis: experience of 69 pregnancies in 61 high risk women. Am J Obstet Gynecol . 1996; 176 1062-1068
54 Montalescot G, Polle V, Collet J. et al . Low molecular weight heparin after mechanical heart valve replacement. Circulation . 2000; 101 1083-1086
55 Lee L H, Liaw P C, Ng A S. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement. Thromb Haemost . 1996; 76 628-630
56 Lev-Ran O, Kramer A, Gurevitch J, Shapira I, Mohr R. Low-molecular-weight heparin for prosthetic heart valves: treatment failure. Ann Thorac Med . 2000; 69 264-266
57 Ellison J, Thomson A J, Walker I D, Greer I A. Use of enoxaparin in a pregnant woman with a mechanical heart valve prosthesis. Br J Obstet Gynaecol . 2001; 108 757-759
58 Roberts N, Ross D, Flint S, Arya R, Blott M. Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin. Br J Obstet Gynaecol . 2001; 108 327-329
59 Rowan J A, McGowan L ME, Raudkivi P J, North R A. Enoxaparin treatment of women with mechanical valves during pregnancy. Am J Obstet Gynecol . 2001; 185 633-637
60 Weatherall D. The hereditary anaemias. Br Med J . 1997; 314 492-496
61 Perry K, Morrison J. Disorders of hemoglobin structure, function and synthesis. In: Gleicher N, Gall S, Sibai B, Elkayam U, Galbraith R, Sarto G, eds. Principles and Practice of Medical Therapy in Pregnancy Norwalk, CT: Appleton & Lange 1992: 1007-1010
62 Blake P, Martin J N, Perry K. Disseminated intravascular coagulation, autoimmune thrombocytopenic purpura and hemoglobinopathies. In: Knupel R, Drukker J, eds. High Risk Pregnancy A Team Approach. Philadelphia: WB Saunders 1993: 561-570
63 Morrison J, Morrison F, Floyd R. et al . Use of continuous flow erythrocytopheresis in pregnant patients with sickle cell disease. J Clin Apher . 1991; 6 224-226
64 Howard R. Management of sickling conditions in pregnancy. Br J Hosp Med . 1996; 56 7-10
65 Howard R, Tuck S, Pearson T. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome. Br J Obstet Gynaecol . 1995; 102 947-951
66 Ricks P. Exchange transfusion in sickle cell anaemia and pregnancy. Obstet Gynecol . 1965; 25 117-121
67 Cunningham F, Pritchard J, Mason R. Pregnancy and sickle cell hemoglobinopathies: results with and without prophylactic transfusion. Obstet Gynecol . 1983; 62 419-423
68 Koshy M, Burd L, Wallace D, Moawad A, Baron J. Prophylactic red cell transfusion in pregnant patients with sickle cell disease: a randomized cooperative study. N Engl J Med . 1988; 319 1447-1452
69 Bellucci S, Janvier M, Tobelem G. et al . Essential thrombocythemias. Clinical evolutionary and biological data. Cancer . 1986; 58 2440-2447
70 Barr I, Cohen P, Berken A, Lown B. Thrombocythemia and myocardial ischemia with normal coronary angiogram. Arch Intern Med . 1974; 134 528-533
71 Okayasu N, Murata M, Ueda A. et al . Primary thrombocythemia and myocardial infarction in a 26-year-old woman with normal coronary arteriogram. Jpn Heart J . 1981; 22 439-445
72 Preston F, Martin J, Stewart R, Davies-Jones G. Thrombocytosis, circulating platelet aggregates, and neurological dysfunction. Br Med J . 1979; 2 1561-1563
73 Hussain S, Schwartz J, Friedman S, Chua S. Arterial thrombosis in essential thrombocythemia. Am Heart J . 1978; 96 31-36
74 Eliyahu S, Shalev E. Essential thrombocythemia during pregnancy. Obstet Gynecol Surv . 1997; 52 243-247
75 Hoagland H, Silverstein M. Primary thrombocythemia in the young patient. Mayo Clin Proc . 1978; 53 578-580
76 Waysbort A, Giroux M, Mansat V. et al . Experimental studies of transplacental passage of alpha interferon by two assay techniques. Antimicrob Agents Chemother . 1993; 37 1323-1327
77 Delage R, Demers C, Cantin G, Roy J. Treatment of essential thrombocythaemia during pregnancy with interferon-alpha. Obstet Gynecol . 1996; 87 814-817
78 Lorincz A, Moore R. Puerperal cerebral venous thrombosis. Am J Obstet Gynecol . 1962; 83 311-318
79 Goldman J, Eckerling B, Gans B. Intracranial venous sinus thrombosis in pregnancy and puerperium: report of 15 cases. J Obstet Gynaecol Br Commun . 1964; 71 791-796
80 Cross J, Castro P, Jennett W. Cerebral strokes associated with pregnancy and the puerperium. Br Med J . 1968; 3 214-218
81 Wiebers D, Whisnant J. The incidence of stroke among pregnant women in Rochester, Minnesota, 1955-1979. JAMA . 1985; 254 3055-3057
82 Simolke G, Cox S, Cunningham F. Cerebrovascular accidents complicating pregnancy and the puerperium. Obstet Gynecol . 1991; 78 37-42
83 Cunningham F, Levenko K. Management of pregnancy-induced hypertension. In: Rubin P, ed. Handbook of Hypertension, vol. 10 Oxford: Elsevier 1988: 209-319
84 Donaldson J. Neurological problems of pregnancy. In: Bradley W, Daroff R, Fenichel G, Marsden C, eds. Neurology in Clinical Practice Boston: Butterworth-Heinmann 1991: 809-815
85 Sharshar T, Lamy C, Mas J. Incidence and causes of strokes associated with pregnancy and puerperium: A study in public hospitals of Ile de France. Stroke . 1995; 26 930-936
86 Kittner S, Stern B, Feeser B. et al . Pregnancy and the risk of stroke. N Engl J Med . 1996; 335 768-774
87 Lanska D, Kryscio R. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke . 2000; 31 1274-1282
88 Weir B, Macdonald N, Mielke B. Intracranial vascular complications of choriocarcinoma. Neurosurgery . 1978; 2 138-142
89 Branch D, Silver R, Blackwell J, Reading J, Scott J. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol . 1992; 80 614-620
90 Newman G, Mitchell J. Homocysteinuria presenting as multiple arterial occlusions. Q Med J . 1984; LIII 251-258
91 Mas J, Lamy C. Stroke in pregnancy and the puerperium. J Neurol . 1998; 245 305-313
92 Lamy C, Hamon J B, Coste J, Mas J L, for the French Study Group on Stroke in Pregnancy. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. Neurology . 2000; 55 269-274
93 Hankins G, Wendel G, Leveno K J, Stoneham J. Myocardial infarction during pregnancy. Obstet Gynecol . 1985; 65 139-146
94 Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. Ann Intern Med . 1996; 125 751-762
95 Yoshimura T, Ito M, Nakamura T, Okamura H. The influence of labor on thrombotic and fibrinolytic systems. Eur J Obstet Gynecol Reprod Biol . 1992; 44 195-199
96 Menallo-Estrella P, Barker A. Histopathologic findings in human aortic media associated with pregnancy. Arch Pathol Lab Med . 1967; 83 336-341
97 Turrentine M, Braems G, Ramirez M. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv . 1995; 50 534-541
98 Hall R, Young C, Sutton G, Campbell S. Treatment of acute massive pulmonary embolism by streptokinase during labour and delivery. Br Med J . 1972; 4 647-649
99 Faghrer B, Ahlgren M, Astedt B. Acute massive pulmonary embolism treated with streptokinase during labor and the early puerperium. Acta Obstet Gynecol Scand . 1990; 69 659-661
100 Ludwig H, Genz H. Thrombolytic treatment during pregnancy. Thromb Haemost . 1981; 46 438
101 Ulm M, Obwegeser R, Ploeckinger B. et al . A case of myocardial infarction complicating pregnancy-a role for prostacyclin synthesis stimulating plasma factor and lipoprotein (a)?. Thromb Res . 1996; 83 237-242
102 American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics . 1994; 93 137-150
103 Shotan A, Widerhorn J, Hurst A, Elkayam U. Risk of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med . 1994; 96 451-456
104 Cohen W, Steinman T, Patsner B. et al . Acute myocardial infarction in a pregnant woman at term. JAMA . 1983; 250 2179-2181